June 4, 2020
Bayer Animal Health brings more technologies to warm-water shrimp farming
To boost its solution offerings for shrimp and other warm-water aquaculture species, Bayer Animal Health has inked supply and distribution agreements with water treatment technology suppliers Cytozyme Laboratories Inc. and Chengdu Kehongda Technology Co. Ltd., and farm management technology provider XpertSea Solutions Inc.
With the agreements, Bayer Animal Health extends to farmers in key shrimp-producing countries greater access to pond water environment management technologies, further enhancing operational efficiency and sustainability, the company said in a news release.
"We are proud to be able to play a leading role in offering shrimp producers an application programme of non-pharmaceutical pond-water treatment products that make up a comprehensive solution. Together with our partners, we are committed to continue bringing technology to shrimp producers and supporting the sustainable development of the industry", said Jan Koesling, global aquaculture manager at Bayer Animal Health.
The aquaculture industry has evolved considerably over the last decade, particularly as stocks from fisheries stagnate or dwindle. To meet growing global seafood demand, the shrimp industry is increasingly turning to warm-water pond aquaculture. This not only contributes to increased production volumes, but also aids the conservation of the oceans' resources.
Today, warm-water pond aquaculture contributes 55% of shrimp produced globally, mostly by small and medium enterprise pond farming. Warm-water pond aquaculture has some distinct advantages. It is not directly connected with the ocean and production utilizes land that is often not suitable to efficiently sustain crops, which in turn brings about economic benefits to the community.
Water treatment solutions' role
In aquaculture water treatment solutions play an important role as they enable producers to manage the complex pond ecosystem and provide an optimal environment for shrimp to thrive. As part of the agreement with water treatment technology supplier Cytozyme (based in Utah, USA), Bayer Animal Health will commercialise Proquatic™ PondRestore, a product that enhances metabolization activities in the pond-soil and pond-water environment, in several key aquaculture countries. The product is already part of Bayer Animal Health's water treatment portfolio in China.
The agreement with China-based Chengdu Kehongda, also a water treatment technology supplier, will enable the rollout of Fetant™ Complex Iodine Solution technology as part of Bayer Animal Health's portfolio in China and Vietnam. This partnership with Chengdu Kehongda follows the inclusion of Dyvon™ PondAcid to Bayer Animal Health's water treatment solution programme in China. The product is a pond-water conditioner that supports the quality of phytoplankton populations and maintains levels of dissolved oxygen in the pond water.
The agreement with XpertSea of Canada, a farm management technology provider, advances digital farming in shrimp aquaculture as it offers smart devices and AI-powered software for a comprehensive approach to data-driven farm management, as part of Bayer's integrated services in China, Ecuador, India and Vietnam.
The devices leverage optics to measure vital pond statistics over time and identify changes in the health of a population. Insights are aggregated into XpertSea's online Growth Platform, which aids producers in making data-driven management and treatment decisions.
Over the last decades, Bayer Animal Health has fine-tuned its offering of water treatment solutions to address the needs of warm-water pond aquaculture customers in different segments. The agreements with Cytozyme, Chengdu Kehongda and XpertSea follow successful pilot projects in China and Vietnam in 2019 and build upon leading umbrella brands ProteAQ™, Proquatic™ and Fetant™.